Previous Close | 0.5199 |
Open | 0.5400 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.5200 - 0.5680 |
52 Week Range | 0.4580 - 1.5500 |
Volume | |
Avg. Volume | 124,115 |
Market Cap | 1.52M |
Beta (5Y Monthly) | 1.50 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2900 |
Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ELMSFORD, N.Y., October 09, 2024--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave ("SAW") Portable Ultrasonic Therapeutic Devices, today announced it has signed a non-binding term sheet for a license and supply agreement with APOGEPHA Arzneimittel GmbH ("APOGEPHA"), a German pharmaceutical company, which specializes in the development, marketing, sales and distribution of urology product
ELMSFORD, N.Y., September 23, 2024--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a letter of intent with Medici Medical LTD ("Medici"), a leading distributor of medical products in the Israeli healthcare market, to explore the opportunities for distribution of the Company’s UroShield device in Israel.